Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications.
Greer
Laura G
LG
From the University of Texas Southwestern Medical Center, Department of Obstetrics and Gynecology, Parkland Health and Hospital System, Dallas, Texas.
Sheffield
Jeanne S
JS
Rogers
Vanessa L
VL
Roberts
Scott W
SW
McIntire
Donald D
DD
Wendel
George D
GD
D000547:Amantadine / Q000009:adverse effects / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D020345:Enterocolitis, Necrotizing / Q000209:etiology; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007251:Influenza, Human / Q000188:drug therapy* / Q000517:prevention & control; D053139:Oseltamivir / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000517:prevention & control; D011256:Pregnancy Outcome; D012299:Rimantadine / Q000009:adverse effects / Q000627:therapeutic use
D000998:Antiviral Agents; D012299:Rimantadine; D053139:Oseltamivir; D000547:Amantadine